Brief: RION Announces First Patient Enrolled In Phase 1B Clinical Study Evaluating Purified Exosome Product For Knee Osteoarthritis
11/03/2025 13:57
March 11 (Reuters) - Rion Co Ltd 6823.T: RION ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1B CLINICAL STUDY EVALUATING PURIFIED EXOSOME PRODUCT™ (PEP™) FOR KNEE OSTEOARTHRITIS Source text: ID:nBw32gVxFa Further company coverage: 6823.T ((reuters.briefs@thomsonreuters.com;))